ZA200801875B - Isoquinolines as IGF-IR inhibitors - Google Patents

Isoquinolines as IGF-IR inhibitors

Info

Publication number
ZA200801875B
ZA200801875B ZA200801875A ZA200801875A ZA200801875B ZA 200801875 B ZA200801875 B ZA 200801875B ZA 200801875 A ZA200801875 A ZA 200801875A ZA 200801875 A ZA200801875 A ZA 200801875A ZA 200801875 B ZA200801875 B ZA 200801875B
Authority
ZA
South Africa
Prior art keywords
igf
isoquinolines
inhibitors
receptor
inhibit
Prior art date
Application number
ZA200801875A
Other languages
English (en)
Inventor
Gunzinger Jan
Leander Kurt
Original Assignee
Analytecon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Analytecon Sa filed Critical Analytecon Sa
Publication of ZA200801875B publication Critical patent/ZA200801875B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200801875A 2005-09-09 2008-02-28 Isoquinolines as IGF-IR inhibitors ZA200801875B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB2005002701 2005-09-09

Publications (1)

Publication Number Publication Date
ZA200801875B true ZA200801875B (en) 2009-08-26

Family

ID=36350070

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200801875A ZA200801875B (en) 2005-09-09 2008-02-28 Isoquinolines as IGF-IR inhibitors

Country Status (19)

Country Link
US (1) US8044067B2 (fr)
EP (1) EP1931636B1 (fr)
JP (1) JP2009507819A (fr)
KR (1) KR20080042897A (fr)
CN (1) CN101258130B (fr)
AT (1) ATE505457T1 (fr)
AU (1) AU2006288846B2 (fr)
BR (1) BRPI0616732A2 (fr)
CA (1) CA2621836C (fr)
DE (1) DE602006021327D1 (fr)
DK (1) DK1931636T3 (fr)
EA (1) EA200800785A1 (fr)
ES (1) ES2364673T3 (fr)
HK (1) HK1115500A1 (fr)
IL (1) IL189883A (fr)
NO (1) NO20081207L (fr)
NZ (1) NZ566524A (fr)
WO (1) WO2007029106A1 (fr)
ZA (1) ZA200801875B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130005733A1 (en) 2010-03-09 2013-01-03 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
CA2825894C (fr) 2011-02-02 2021-11-30 Amgen Inc. Pronostic de cancer au moyen de biomarqueur en circulation
CN103732592A (zh) * 2011-04-21 2014-04-16 默沙东公司 胰岛素样生长因子-1受体抑制剂
WO2013071056A2 (fr) 2011-11-11 2013-05-16 Duke University Polythérapie médicamenteuse pour le traitement de tumeurs solides
US8980259B2 (en) 2012-07-20 2015-03-17 Novartis Ag Combination therapy
CN104672136B (zh) * 2013-11-30 2017-01-25 沈阳药科大学 1‑取代菲基‑n‑烷基(酰基)‑6,7‑二甲氧基‑1,2,3,4‑四氢异喹啉衍生物及其制备方法和用途
WO2017129763A1 (fr) 2016-01-28 2017-08-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes et compositions pharmaceutiques pour le traitement du cancer de l'estomac à cellules en bague à chaton
WO2020191151A1 (fr) * 2019-03-19 2020-09-24 Oncovalent Therapeutics Inc. Composés inhibiteurs de sumo et leurs utilisations
CN114456184B (zh) * 2022-02-21 2023-08-22 南华大学附属第一医院 一种3-芳基异喹啉衍生物及其制备与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ519146A (en) * 1999-11-03 2004-02-27 Albany Molecular Res Inc 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
SE0203746D0 (sv) * 2002-12-18 2002-12-18 Karolinska Innovations Ab New compounds
CN100590118C (zh) * 2004-03-12 2010-02-17 阿纳里特康股份有限公司 作为类胰岛素生长因子第1类受体抑制剂的杂环化合物

Also Published As

Publication number Publication date
IL189883A0 (en) 2008-11-03
ES2364673T3 (es) 2011-09-12
AU2006288846B2 (en) 2011-08-18
AU2006288846A1 (en) 2007-03-15
BRPI0616732A2 (pt) 2013-01-01
CA2621836C (fr) 2013-11-12
ATE505457T1 (de) 2011-04-15
EP1931636A1 (fr) 2008-06-18
NZ566524A (en) 2011-01-28
DE602006021327D1 (de) 2011-05-26
EP1931636B1 (fr) 2011-04-13
WO2007029106A1 (fr) 2007-03-15
CN101258130A (zh) 2008-09-03
US20090099229A1 (en) 2009-04-16
JP2009507819A (ja) 2009-02-26
KR20080042897A (ko) 2008-05-15
HK1115500A1 (en) 2008-11-28
DK1931636T3 (da) 2011-07-25
NO20081207L (no) 2008-05-27
CN101258130B (zh) 2012-11-28
EA200800785A1 (ru) 2008-08-29
US8044067B2 (en) 2011-10-25
CA2621836A1 (fr) 2007-03-15
IL189883A (en) 2012-07-31

Similar Documents

Publication Publication Date Title
ZA200801875B (en) Isoquinolines as IGF-IR inhibitors
SG163585A1 (en) Melanocortin receptor ligands
TN2011000279A1 (en) Novel pyrazole -4-n-alkoxycarboxamides as microbiocides
TN2010000101A1 (en) Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives
GEP20125564B (en) Pyrimidine derivatives as kinase inhibitors
MX2009003834A (es) Derivados de pirrolidina como inhibidores de iap.
MX2007013632A (es) Procedimientos para preparar derivados de bencil-benceno sustituidos con glucopiranosilo y sus productos intermedios.
MX2011012366A (es) Mezclas fungicidas sinergeticas.
MX2009005934A (es) Compuestos organicos.
TW200716584A (en) Dihydrobenzofuran derivatives and uses thereof
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
MX2009005048A (es) Nuevo proceso para la preparacion de derivados de 2-imino-tiazolidin-4-ona.
TN2010000064A1 (en) Novel herbicides
MX2009011205A (es) Derivados de 2-iminoisotiazol como ligandos del receptor canabinoide.
UA103625C2 (en) 5-hetrocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enons as herbicides
MX2010001364A (es) Derivados de ciclopentandiona puenteados triciclicos como herbicidas.
PT1877367E (pt) Derivados do acetileno
WO2008156677A3 (fr) Ligands peptidiques cycliques des récepteurs de la mélanocortine
TW200730511A (en) Chroman compounds
WO2008151828A8 (fr) Nouveaux microbiocides
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
WO2009127718A3 (fr) Nouveaux microbiocides
TW200730510A (en) Chroman compounds
TW200738713A (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
TN2011000355A1 (en) Novel microbiocides